Bicara Therapeutics Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $-74.8M | $-74.8M | $71.0K | $7.4M |
| FY2025 | $-106.8M | $-107.1M | $280.0K | $15.0M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $-74.8M | $-74.8M | $71.0K | $7.4M |
| FY2025 | $-106.8M | $-107.1M | $280.0K | $15.0M |